PCRX: Pacira BioSciences, Inc.
Performance
PCRX +65.35%
Watchlist
Select an item
Summary
PCRX at a glance
PCRX returned +65.35% over the past year and -8.87% a year over five years. Its worst drop in that year was -28.19%, smaller than 62% of stocks on Redstone, and its Sharpe ratio of 1.07 beats 79% of stocks on Redstone. It pays no dividends.
Current Drawdown
0.00%
Rolling Volatility
1.64%
Actions
Metrics
Risk Indicators
Alpha60.15%
Beta0.07x
Sharpe1.07
Sortino2.26
Omega1.31
Calmar2.32
Martin5.33
Profile
About PCRX
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.5B
- Listed
- Feb 2011
- Employees
- 829
- Headquarters
- Brisbane, CA
- Website
- pacira.com
Comparisons